Free Telemedicine Solution Offered to Healthcare Providers by CompuGroup Medical

Looking for ways to slow the spread of the COVID-19 coronavirus and protect the health of practice staff and the public, medical providers are expressing an increased demand for telemedicine.

CompuGroup Medical reports CGM ELVI Telemedicine allows providers to collect patient information; share images, vitals, and findings; provide care from anywhere at any time; initiate treatments and therapies rapidly; offer continuous care to immobile patients; and reduce the workload of practice staff—all without the risk of spreading infection.

“CGM is one of the leading eHealth companies in the world,” said Benedikt Brueckle, Chief Executive Officer, CompuGroup Medical US. “We are committed to using our position to help the medical community contain the coronavirus, and that’s why we decided to offer a free, six-month subscription to CGM ELVI.”

In its community mitigation guidelines to prevent pandemic influenza, the CDC outlined the importance of flattening the curve, or reducing the number of cases and related demands on hospital and infrastructure while slowing the acceleration of the number of cases.

“The response to this program has been inspiring,” Brueckle said.

Last week, the United States enacted an emergency spending package that includes $500 million to allow Medicare providers to extend telemedicine services to seniors, regardless of where they live.

“It is our hope that the funding from Congress and our offer to provide six months of CGM ELVI electronic video conferencing at no charge will combine to greatly improve the American response to and containment of COVID-19,” Brueckle said.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Importantly, the study reported no serious treatment-related adverse events from any of the 109 patients treated with InGeneron’s Transpose® RT cell therapy system.
The decision cancels each of the original claims of the '345 Patent and declares unpatentable each of Swift's proposed substitute claims. Amongst the prior art deemed by the USPTO to render the '345 Patent unpatentable is a patent application licensed to MolecuLight that lists MolecuLight's Founder, Dr. Ralph DaCosta, as the sole inventor.
It combines the convenience of the Kaleido insulin pump with two market-leading innovations designed by Diabeloop and Dexcom to create a Hybrid Closed Loop system for managing type 1 diabetes which is flexible, self-learning and easy to use.
SYNICEM spacers are antibiotic-loaded, preformed spacers which overcome the challenges of traditional intra-operative moulded and handmade spacers. They help support surgeons' revisions of the hip, knee and shoulder by preserving articular space and aiding the treatment of infection.
This article courtesy of infomeddnews.com delves into the critical steps for launching a successful medical startup, while also highlighting the importance of a strong visual identity, achievable through tools like online logo makers.

By using this website you agree to accept Medical Device News Magazine Privacy Policy